Physician profile
Pradeep Singh
NPI 1659327997
$6,616.90
in general payments reported to CMS, 2019-2025
35 companies · $566 in 2025
The $566 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $733 · 2020: $1,064 · 2021: $909 · 2022: $1,368 · 2023: $1,027 · 2024: $951 · 2025: $566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,544.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,543.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Artivion, INC. | $1,189.41 | 2020-2021 | |
| Boston Scientific Corporation | $932.17 | 2019-2025 | Watchman Flx, Avvigo Guidance System, General - Molecular Intervention |
| E.R. Squibb & Sons, L.L.C. | $622.85 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $403.27 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $301.86 | 2019-2023 | Lifevest |
| Merck Sharp & Dohme LLC | $263.32 | 2022-2025 | Verquvo, Winrevair |
| Abbott Laboratories | $229.77 | 2021-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Biotronik INC. | $217.85 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $217.47 | 2019-2021 | |
| Abiomed | $204.04 | 2021-2022 | |
| Edwards Lifesciences Corporation | $194.16 | 2019-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Novo Nordisk INC | $192.42 | 2023-2024 | Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $158.28 | 2022-2023 | |
| Penumbra, INC. | $142.80 | 2022 | |
| Inspire Medical Systems, INC. | $140.33 | 2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $129.75 | 2021-2022 | |
| Amarin Pharma, INC. | $125.00 | 2019 | |
| Scpharmaceuticals INC. | $125.00 | 2024 | |
| Janssen Pharmaceuticals, INC | $111.93 | 2022-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $111.24 | 2023 | Jardiance |
| Stability Biologics, LLC | $104.67 | 2023 | |
| Livanova USA, INC. | $103.43 | 2019 | |
| Pfizer INC. | $67.33 | 2019-2025 | |
| Kestra Medical Technology Services, INC. | $49.75 | 2024-2025 | Assure Wcd |
| Tactile Systems Technology INC | $48.75 | 2021-2023 | Flexitouch Plus, Entre Plus |
| Lexicon Pharmaceuticals, INC. | $46.77 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $32.22 | 2021 | |
| Amgen INC. | $28.92 | 2019-2020 | |
| Getinge USA Sales, LLC | $24.75 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $24.51 | 2024 | Arcalyst |
| Davol INC. | $17.36 | 2025 | Avitene Ultrafoam |
| Cleerly, INC. | $15.90 | 2024 | Cleerly Ischemia, Cleerly Labs |
| Medtronic, INC. | $15.41 | 2025 | Ffrangio |
| Kowa Pharmaceuticals America, INC. | $12.72 | 2019 | |
| Medtronic Vascular, INC. | $11.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pradeep Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.